LeafNLP Demos
Back to explore

Report #2886781

Received Feb 25, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
39 yrs
State
CA
Recovered
Unknown
Vaccinated
Feb 12, 2026
Onset
Feb 12, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MMRMEASLES + MUMPS + RUBELLA (PRIORIX)GLAXOSMITHKLINE BIOLOGICALSUNKMS9ANIM

Symptoms (1)

Incorrect route of product administration

Symptom narrative

Patient received a Priorix vaccine intramuscular instead of subcutaneous; This non-serious case was reported by the other health professional via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a 39-year-old female patient who received MMR (Priorix) (batch number MS9AN) for prophylaxis. On 12-FEB-2026, the patient received Priorix (intramuscular). On 12-FEB-2026, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: Patient received a Priorix vaccine intramuscular instead of subcutaneous). The outcome of the subcutaneous injection formulation administered by other route was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 19-FEB-2026